COVID-19 patients responded positively to remdesivir, says maker

Kindly Share This Story:

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP

Gilead Science’s remdesivir, one of the most highly anticipated drugs being tested against the new coronavirus, showed positive results in a large-scale US government trial, the company said Wednesday.

“We understand that the trial has met its primary endpoint and that NIAID (National Institute of Allergy and Infectious Diseases) will provide detailed information at an upcoming briefing,” the company said.



[AFP]

Newzandar News News Nigeria.

Kindly Share This Story:

Source

Be the first to comment

Leave a Reply

Your email address will not be published.


*


87  −    =  82